Bergen, Norway, July 23, 2025 – Cytovation ASA, a clinical stage oncology company focused on the development of its first-in-class bifunctional peptide CY-101, announces that the International Nonproprietary Names (INN) Expert Committee of the World Health Organization (WHO-INN) has approved "getacatetide" as the International Nonproprietary Name (INN) of CY-101.
Largest commercial insurer in the United States releases positive comprehensive coverage for AI-enabled Heartflow Plaque Analysis to support precise diagnosis and management of patients
Largest commercial insurer in the United States releases positive comprehensive coverage for AI-enabled Heartflow Plaque Analysis to support precise diagnosis and management of patients
Join Army leaders, tech innovators, and defense decision makers in Michigan, Aug. 12 - 14, as defense modernization accelerates the readiness and future capabilities...
FORNEBU, Norway, July 15, 2025 /PRNewswire/ -- Aker Horizons ASA (OSE: "AKH"), a developer of green energy and industry, today announced results for the...
FORNEBU, Norway, July 15, 2025 /PRNewswire/ -- Aker Horizons ASA (OSE: "AKH"), a developer of green energy and industry, today announced results for the...
FORNEBU, Norway, July 15, 2025 /PRNewswire/ -- Aker Horizons ASA (OSE: "AKH"), a developer of green energy and industry, today announced results for the...
ESPOO, Finland, July 14, 2025 /PRNewswire/ -- Beneq, a global leader in Atomic Layer Deposition (ALD) technology, is proud to announce significant progress in...
STOCKHOLM, July 14, 2025 /PRNewswire/ -- Skanska has signed a contract with Fazer to build their new chocolate factory in Lahti, Finland. The contract...
NEW YORK, July 11, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global high-speed cables market is observing...
NEW YORK, July 11, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global high-speed cables market is observing...